New scrutiny of outpatient therapy with I-131

Clinical Nuclear Medicine

Volumn 36, Issue 3, 2011, Pages 206-208

  Harolds, Jay A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

I 131 therapy; outpatient treatment with I 131

Indexed keywords

IODINE 131; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CAREGIVER; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG SAFETY; HUMAN; OUTPATIENT; PHYSICIAN; THYROID CANCER;

GUIDELINES AS TOPIC; HOSPITALIZATION; HUMANS; IODINE RADIOISOTOPES; OUTPATIENTS; PUBLIC HEALTH;

EID: 79951621803     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31820b860b     Document Type: Article

References (28)

1. 1311 Therapy. Radiat Safe J. 2002;83(suppl 5):S71-S84. (Pubitemid 35447079)
2. Tuttle WK, Brown PH. Applying Nuclear Regulatory Commission guidelines to the release of patients treated with sodium iodine-131. J Nucl Med Technol. 2000;28:275-279. (Pubitemid 32039165)
3. US Nuclear Regulatory Commission. Criteria for the Release of Individuals Administered Radioactive Material. Washington, DC: Nuclear Regulatory
4. NRC. Regulatory Guide 8.39: Release of Patients Administered Radioactive Materials. 1997. Available at http://www.nrc.org/nrc/rg/08/index.html. UnderReference Library/Regulatory Guides/Occupational.Health/Guide 8.39.
5. National Council on Radiation Protection and Measurements. Precautions in the Management of Patients Who Have Received Therapeutic Amounts of Radionuclides. Washington, DC: NCRP; 1970. NCRP Report No. 37.
6. 1311for thyroid cancer. J Nucl Med Technol. 2005;33:28-30. (Pubitemid 44783751)
7. Achey B, Miller KL, Erdman M, et al. Some experiences with treating thyroid cancer patients. Radiat Saf J. 2001;80(suppl 2):S62-S66. (Pubitemid 32298850)
8. 131 I outpatient therapy. J Nucl Med Technol. 2002;30:165-171.
9. International Commission on Radiological Protection. Release of Patients After Therapy With Unsealed Radionuclides. 2004. Publication 94.
10. US Nuclear Regulatory Commission. Appendix U, Model Procedure for Release of Patients or Human Research Subjects Administered Radioactive Materials. Vol. 9, Revision 1. Washington, DC: US Nuclear Regulatory Commission; 2005. NUREG-1556.
11. Siegel JA, Marcus CS, Stabin MG. Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with I-131. Health Phys. 2007;93:667-677. (Pubitemid 350098504)
12. US Nuclear Regulatory Commission. Regulatory Issue Summary (RIS) 2008-11 "Precautions to Protect Children Who May Come in Contact With Patients Released After Therapeutic Administration of Iodine-131." US Nuclear Regulatory Commission; 2008.
13. 1311 treatment. J Nucl Med. 2008;4916N.
14. Siegel JA, Silberstein EB. A closer look at the latest NRC patient release guidance [commentary]. J Nucl Med. 2008;49:17N-20N.
15. Grigsby PW, Siegel BA, Baker S, et al. Radiation exposure from outpatient radioactive I-131 therapy from thyroid carcinoma. JAMA. 2000;283:2272-2274. (Pubitemid 30246779)
16. Federal Register. Volume 73, No. 99, 2008.
17. Available at: http://markey.house.gov/docs/STAFF-REPORT-031810-FINAL- with-crest.pdf.
18. US Nuclear Regulatory Commission (NRC). Response to January 14, 2010 Information Request by Representative Edward J. Markey, Chairman. Subcommittee on Energy and Environment. Washington, DC: US Nuclear Regulatory Commission (NRC); 2010.
19. National Council on Radiation Protection and Measurements. Management of Radionuclide Therapy Patients. Bethesda, MD: National Council on Radiation Protection and Measurements; 2006. NCRP Report No. 155.
20. Wahl RL. Medical Isotope Shortage, Patient Release and Occupational Exposure Criteria. Rockville, MD: Nuclear Regulatory Commission (NRC); October 20, 2010.
21. Langhorst SM. Briefing on Review of Patient Release Issues 10 CFR 35.75. Rockville, MD: NRC; October 20, 2010.
22. The Endocrine Society, The American Thyroid Association, the SNM, the American Association of Clinical Endocrinologists. Joint statement on radioactive precautions following radioactive iodine therapy. Press Release. October 20, 2010.
23. SNM. Current federal regulations help thyroid cancer patients and protect public safety. Press Release. October 21, 2010.
24. Available at: http://snm.org/guidelines.
25. Wald ML. When a cancer therapy puts others at risk. New York Times. October 24, 2010. Available at: http://www.nytimes.com/2010/10/25/health/policy/ 25radiation.html?scp-2&sq-thyroid&st-cse.
26. Delbeke D, Graham MM, Segall GM. Weighing Radiation Risks [Letter to the editor]. 2010. Available at: http://www.nytimes.com/2010/10/31/opinion/ 131cancer.html?-r-2&ref-letters.
27. Siegal JA, Stabin MG. RADAR response to IAEA position statement on release of radionuclide therapy patients. Health Physics News. May 2010; XXXVIII:6-7.
28. Advisory Committee on the Medical Use of Isotopes (ACMUI) to the NRC. Patient Release Report. December 13, 2010. Available on the ACMUI's public website under Related Information: http://www.nrc.gov/about-nrc/regulatory/ advisory/acmui.html.